Myopia Management
Independent medical education supported by EssilorLuxottica, Hoya, Cooper Vision
Videos
IME Webinar Series #1
Comprehensive Update on Myopia Management - Q&A; Session
Symposium Part #1:
Comprehensive Update on Myopia Management
Symposium Part #2:
Comprehensive Update on Myopia Management
Interview 1:
Patient education and
genetic risk factors
Interview 2:
Balancing the use of spectacles, contact lenses, and pharmaceuticals
Interview 3:
Behavioral modification
and other considerations
Podcasts
Episode 1:
Patient education and genetic risk factors
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga discuss the myopia epidemic, potential underlying genetic risk factors and how to educate patients and the community about it. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
Episode 2:
Balancing the use of spectacles, contact lenses, and pharmaceuticals
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga review various currently available treatment options to manage myopia progression. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
Episode 3:
Behavioral modification and other considerations
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga speak about the importance of behavioral modification in the management of myopia patients and other considerations. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
eLearning
The Global Myopia Epidemic & Its Clinical Consequences
This independent medical education elearning content is supported by EssilorLuxottica, Hoya, and Cooper Vision.
This content has been developed to help you better understand the global myopia epidemic, and its causes, as well as the clinical implications of high myopia for you as a clinician and your patients.
The Clinical Impact of Myopia & First Line Treatment
This independent medical education elearning content is supported by EssilorLuxottica, Hoya, and Cooper Vision.
This content has been developed to help you better understand the clinical impact of myopia – the considerations for patients, parents and you; and also to help you explore behaviour modification as the first-line treatment in myopia.
Improving Public and Patient Understanding of Myopia
This independent medical education elearning content is supported by EssilorLuxottica, Hoya, and Cooper Vision.
In this module, you will explore some ways to make parents, patients and other health professionals more aware of the myopia epidemic and what can be done about it by developing your professional network and through patient education.
